Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.US DoJ clears AstraZeneca’s clinical trial
AstraZeneca was hit with claims from outside medical professionals that it reportedly had rigged PLATO clinical trials involving 18,624 patients in 43 nations, in a bid to furnish
AstraZeneca was hit with claims from outside medical professionals that it reportedly had rigged PLATO clinical trials involving 18,624 patients in 43 nations, in a bid to furnish
The deal would offer Recipharm with access to highly interesting geographical regions including Italy and several other emerging markets, many of them being new to Recipharm. Further, Recipharm
Specifically, the nitric oxide-releasing technology was found to be effective against Acinetobacter baumannii, a gram-negative bacterium resistant to nearly all antibiotics, which causes pneumonia, urinary tract infection, and
The aproval follows two clinical trials that evaluated the safety and effectiveness of Cerdelga in 199 participants with the disease that is estimated to affect nearly 6,000 people
The agreement also includes an option for Novartis to acquire the rest of the company for a cash payment of approximately $165m. In addition, Gamida Cell will be
So far, Acetylcysteine Solution, USP vial for inhalation (mucolytic agent) or oral administration has been on the drug-shortage lists maintained by both the US Food and Drug Administration
The trial is being carried out at Columbia University and the New York State Psychiatric Institute, and led by Dr. Sandra Comer, Professor of Neurobiology and principal investigator.
These technologies are applicable to EastGate’s existing pharmaceutical products in development and can also be employed as effective platforms for delivery of other biologically active compounds. The company
The company, which has the worldwide exclusive license to develop and market GBV006, is seeking approval for the use of the product, a combination of Food and Drug
The NDA requests FDA approval of palbociclib, in combination with letrozole, for the treatment these women. The filing is based on the final results of PALOMA-1, a randomized,